| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.48 (Miss by $-0.01) |
| EPS GAAP Actual | $0.48 (Miss by $-0.01) |
| Revenue Actual | $-1.43384B |
| Revenue Surprise | Beat by $-1433.84M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $4.16479 |
| EPS GAAP Estimate | $4.16479 |
| Revenue Estimate | $2.00706072B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 2.01166 | 11.46 | 1.93743 | 2.07201 | 1 |
| Dec 2027 | 14.64554 | 1.57 | 14.22514 | 15.15205 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -11.08 | -14.77841 | -1.43384B | 223.76% | -3426.25M |
| FQ2 2025 (Jun 2025) | 13.44 | 9.75145 | 1.75812B | -6.51% | -136.85M |
| FQ1 2025 (Mar 2025) | 11.52 | 7.81299 | 1.45382B | -10.68% | -149.8M |
| FQ4 2024 (Dec 2024) | 2.17 | -1.57174 | 1.78344B | -7.18% | -107.42M |
| FQ3 2024 (Sep 2024) | 3.5 | 1.96263 | 1.77453B | -7.41% | -2037.53M |
| FQ2 2024 (Jun 2024) | 4.2 | 2.86165 | 1.87255B | 2.11% | -1463M |
| FQ3 2012 (Sep 2012) | 0.68 | 0.68 | 0.207331B | 100% | 207.33M |
| FQ1 2024 (Mar 2024) | 3.12 | 2.47 | 1.60906B | 4.69% | 490.41M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
4.16479
Consensus Revenue Estimates
2.00706072B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.53337 | -- | 0.51342 | 0.5507 | 1 |
| FQ3 2026 (Sep 2026) | 0.57768 | 2018.02 | 0.55843 | 0.59782 | 1 |
| FQ2 2026 (Jun 2026) | 0.59564 | -2156.4 | 0.57579 | 0.61641 | 1 |
| FQ1 2026 (Mar 2026) | 0.37345 | -2984.75 | 0.35948 | 0.38558 | 1 |
| FQ4 2025 (Dec 2025) | 4.16479 | 47.9 | 4.00794 | 4.38705 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.27B | -- | 0.26B | 0.28B | 2 |
| FQ3 2026 (Sep 2026) | 1.64B | 187.55 | 1.6B | 1.68B | 2 |
| FQ2 2026 (Jun 2026) | 1.66B | -6.05 | 1.62B | 1.7B | 2 |
| FQ1 2026 (Mar 2026) | 0.18B | -706.56 | 0.18B | 0.18B | 2 |
| FQ4 2025 (Dec 2025) | 2.01B | 11.14 | 1.95B | 2.09B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
2
Revenue # of Misses
6
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.69841 | -11.08 | -14.77841 | 133.38% |
| FQ2 2025 (Jun 2025) | 3.68855 | 13.44 | 9.75145 | 72.56% |
| FQ1 2025 (Mar 2025) | 3.70701 | 11.52 | 7.81299 | 67.82% |
| FQ4 2024 (Dec 2024) | 3.74174 | 2.17 | -1.57174 | -72.43% |
| FQ3 2024 (Sep 2024) | 1.53737 | 3.5 | 1.96263 | 56.08% |
| FQ2 2024 (Jun 2024) | 1.33835 | 4.2 | 2.86165 | 68.13% |
| FQ3 2012 (Sep 2012) | 0.68 | 0.68 | 100% | |
| FQ1 2024 (Mar 2024) | 0.65 | 3.12 | 2.47 | 79.17% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.99B | $-1.43B | $-3426.25M | 238.96% |
| FQ2 2025 (Jun 2025) | $1.89B | $1.76B | $-136.85M | -7.78% |
| FQ1 2025 (Mar 2025) | $1.6B | $1.45B | $-149.8M | -10.3% |
| FQ4 2024 (Dec 2024) | $1.89B | $1.78B | $-107.42M | -6.02% |
| FQ3 2024 (Sep 2024) | $3.81B | $1.77B | $-2037.53M | -114.82% |
| FQ2 2024 (Jun 2024) | $3.34B | $1.87B | $-1463M | -78.13% |
| FQ3 2012 (Sep 2012) | $0B | $0.21B | $207.33M | 100% |
| FQ1 2024 (Mar 2024) | $1.12B | $1.61B | $490.41M | 30.48% |